EMVision Medical Devices Limited provide an update on the progress of its clinical trial. Following discussions with lead investigators, the Company has now recommenced stroke patient enrolment at the Princess Alexandra Hospital in Brisbane. EMVision continues to closely monitor the impact of the Covid-19 pandemic on its activities. The Company's ability to continue to progress stroke patient enrolment in accordance with its proposed trial timeframe will depend on its ability to continue to access resources, such as suitably qualified personnel, over the coming months. The Company expects to provide updates to the market as it reaches further relevant milestones throughout the clinical testing.